HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wen Di Selected Research

4- ((3- bromophenyl)amino)- 6,7- dimethoxyquinazoline

8/2008Priming with EGFR tyrosine kinase inhibitor and EGF sensitizes ovarian cancer cells to respond to chemotherapeutical drugs.
9/2005Transient activation of EGFR/AKT cell survival pathway and expression of survivin contribute to reduced sensitivity of human melanoma cells to betulinic acid.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wen Di Research Topics

Disease

65Neoplasms (Cancer)
07/2022 - 07/2005
55Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 11/2005
16Neoplasm Metastasis (Metastasis)
12/2021 - 10/2006
13Ovarian Epithelial Carcinoma
04/2021 - 05/2013
8Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 08/2013
6Squamous Intraepithelial Lesions
09/2022 - 08/2020
6Papillomavirus Infections
12/2021 - 01/2009
6Carcinoma (Carcinomatosis)
01/2021 - 09/2012
6Hemorrhage
01/2020 - 09/2014
5Hypoxia (Hypoxemia)
09/2020 - 06/2009
5Endometrial Neoplasms (Endometrial Cancer)
06/2020 - 07/2005
4Infections
06/2021 - 01/2009
4Pre-Eclampsia (Preeclampsia)
01/2021 - 01/2014
4Spontaneous Abortion (Miscarriage)
06/2018 - 10/2008
4Cicatrix (Scar)
08/2017 - 03/2012
4Endometriosis
01/2017 - 04/2011
3Hypertension (High Blood Pressure)
11/2021 - 01/2020
3Carcinogenesis
01/2019 - 10/2009
2Abdominal Pain (Pain, Abdominal)
12/2021 - 09/2014
2Uterine Cervical Dysplasia
12/2021 - 02/2019
2Uterine Hemorrhage (Uterine Bleeding)
12/2021 - 03/2012
2Premature Birth (Birth, Premature)
11/2021 - 01/2018
2Stomach Neoplasms (Stomach Cancer)
04/2021 - 01/2018
2Aneuploidy (Aneuploid)
01/2021 - 02/2017
2Autoimmune Diseases (Autoimmune Disease)
06/2020 - 11/2010
2Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
03/2020 - 01/2013
2Drug-Related Side Effects and Adverse Reactions
01/2020 - 05/2013
2Adenocarcinoma
01/2017 - 04/2013
2Breast Neoplasms (Breast Cancer)
10/2015 - 02/2014
1Vulvar Lichen Sclerosus
09/2022
1Ovarian Teratoma
06/2022

Drug/Important Bio-Agent (IBA)

15Cisplatin (Platino)FDA LinkGeneric
01/2020 - 06/2009
13Proteins (Proteins, Gene)FDA Link
11/2020 - 06/2009
10Pharmaceutical PreparationsIBA
08/2019 - 10/2008
9MicroRNAs (MicroRNA)IBA
05/2021 - 04/2011
9Paclitaxel (Taxol)FDA LinkGeneric
01/2020 - 11/2005
7Small Interfering RNA (siRNA)IBA
01/2020 - 01/2014
51-phenyl-3,3-dimethyltriazene (PDT)IBA
09/2022 - 01/2019
5ErbB Receptors (EGF Receptor)IBA
05/2021 - 01/2014
5DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2013
5Biomarkers (Surrogate Marker)IBA
06/2020 - 01/2018
5Epidermal Growth Factor (EGF)IBA
05/2014 - 10/2006
4Insulin (Novolin)FDA Link
05/2021 - 02/2014
4sphingosine kinaseIBA
04/2021 - 09/2017
4EnzymesIBA
03/2020 - 06/2009
4Phosphotransferases (Kinase)IBA
02/2020 - 11/2005
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016 - 10/2009
3AcidsIBA
12/2021 - 08/2013
3Anticardiolipin AntibodiesIBA
11/2021 - 10/2008
3CholesterolIBA
05/2021 - 03/2020
3Messenger RNA (mRNA)IBA
09/2020 - 01/2019
3LigandsIBA
02/2020 - 08/2008
3Transcription Factors (Transcription Factor)IBA
01/2020 - 01/2014
3Caspase 3 (Caspase-3)IBA
01/2019 - 06/2009
3SphingosineIBA
09/2017 - 11/2010
2AntibodiesIBA
06/2022 - 10/2008
2Annexin A2 (Annexin II)IBA
01/2022 - 01/2018
2Long Noncoding RNAIBA
12/2021 - 08/2019
2Immunoglobulin M (IgM)IBA
11/2021 - 11/2020
2Immunosuppressive Agents (Immunosuppressants)IBA
11/2021 - 11/2010
2Liposomes (Liposome)IBA
05/2021 - 05/2014
2AndrogensIBA
05/2021 - 01/2019
2Blood Glucose (Blood Sugar)IBA
05/2021 - 01/2018
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021 - 10/2006
2RNA (Ribonucleic Acid)IBA
09/2020 - 01/2020
216S Ribosomal RNAIBA
08/2020 - 08/2019
2ChemokinesIBA
02/2020 - 01/2020
2IsoenzymesIBA
01/2020 - 02/2014
2PlatinumIBA
01/2020 - 05/2013
2CytokinesIBA
11/2019 - 01/2009
2ImmunosorbentsIBA
11/2019 - 04/2013
2Insulin ReceptorIBA
01/2019 - 02/2014
2Antineoplastic Agents (Antineoplastics)IBA
01/2019 - 01/2017
2NucleotidesIBA
12/2017 - 02/2017
2Phosphates (Orthophosphate)IBA
09/2017 - 03/2014
2Sphingosine-1-Phosphate ReceptorsIBA
09/2017 - 02/2014
2AnticoagulantsIBA
08/2016 - 07/2013
2Progesterone Receptors (Progesterone Receptor)IBA
03/2014 - 07/2005
2Fingolimod Hydrochloride (FTY720)FDA Link
06/2013 - 11/2010
2matrigelIBA
05/2013 - 01/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2013 - 10/2009
2Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
01/2013 - 10/2009
2Interleukin-8 (Interleukin 8)IBA
03/2012 - 01/2009
2Annexin A5IBA
12/2009 - 06/2009
2CurcuminIBA
12/2008 - 10/2008
24- ((3- bromophenyl)amino)- 6,7- dimethoxyquinazolineIBA
08/2008 - 09/2005
2SurvivinIBA
11/2005 - 09/2005
1Metal-Organic FrameworksIBA
07/2022
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
06/2022

Therapy/Procedure

21Therapeutics
12/2021 - 10/2006
14Drug Therapy (Chemotherapy)
01/2022 - 11/2005
4Immunotherapy
01/2021 - 02/2010
3Aftercare (After-Treatment)
12/2021 - 03/2012
3Photochemotherapy (Photodynamic Therapy)
12/2021 - 03/2021
3Operative Surgical Procedures
01/2021 - 01/2020
3Cesarean Section (Caesarean Section)
01/2018 - 01/2017
3Curettage
09/2014 - 08/2009
2Induced Abortion (Induced Abortions)
06/2018 - 07/2015
2Uterine Artery Embolization
09/2014 - 03/2012
2Hysterectomy
08/2009 - 07/2005